NMRA 10-Q: SEC filing

Neumora Therapeutics

Filed with the SEC on · accession 0001193125-26-462194

NMRA filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -13.8% by the first close after the filing.

Summary of the filing

Neumora Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results including cash position, R&D and G&A expenses, and details of its license agreements and loan facilities.

Key details

FilerNeumora Therapeutics, Inc.
LicensorAmgen Inc.
LicensorVanderbilt University
LenderK2 HealthVentures LLC
Merger counterpartyBlackthorn Therapeutics, Inc.
Funding partnerParkinson's Research Ventures

How NMRA stock reacted

Close before

$0.43

Nov 13, 2026

First close after

-13.85%

$0.37

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for NMRA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NMRA?

Click here

Frequently asked questions

What did NMRA file with the SEC on Nov 16, 2026?

NMRA filed a 10-Q (SEC filing). Neumora Therapeutics filed its quarterly 10-Q report for Q3 2026, disclosing financial results including cash position, R&D and G&A expenses, and details of its license agreements and loan facilities.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did NMRA stock react to this filing?

NMRA closed at $0.43 before the filing and $0.37 on Nov 16, 2026 (-13.85%).

Other NMRA SEC filings

Get alerts when NMRA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days